Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
With new drug development, a significant increase in sales, and high potential with Mounjaro and Zepbound, here’s what we think of Eli Lilly’s stock ...
MoneyShow's Best Investment Ideas For 2025: Part 7
MoneyShow presents top investment ideas for 2024 from leading advisors. Part 7 includes Village Super Market, MARA Holdings, ...
Which issues will be top of mind for leaders in 2025? AI, of course, but it’s just the beginning
The trio discusses the issues they think will be top of mind for company leaders this year. AI, of course, takes the top spot ...
Eli Lilly's SWOT analysis: stock soars on GLP-1 success, faces competition challenges
Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been making waves in the healthcare sector with its groundbreaking treatments for ...
MM&M16h
The Escalator: Pfizer, Real Chemistry, Kailera Therapeutics and more
Archbow Consulting announced Justine Hughes has been promoted to EVP of principal operations while Honora Gabriel and Rob ...